Ascletis PharmaASCLF -4.00%38 Days Inventory is 1,126.22 as of Dec. 2025, which is 90% above its 10-year median of 592.73. GuruFocus rates ASCLF with a GF Score™ of 38/100 and a GF Value™ of $0.02 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 638 Biotechnology companies, Ascletis Pharma ranks worse than 90.13% on this metric.
The historical rank and industry rank for Ascletis Pharma's Days Inventory or its related term are showing as below:
ASCLF'
s Days Inventory Range Over the Past 10 Years
Min: 161.11 Med: 592.73 Max: 3528.02
Current: 887.2
During the past 10 years, Ascletis Pharma's highest Days Inventory was 3528.02. The lowest was 161.11. And the median was 592.73.
ASCLF's Days Inventory is ranked worse than 90.13% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs ASCLF: 887.20
Ascletis Pharma's Days Inventory
declined
from Dec. 2024 (1,818.92) to Dec. 2025 (1,126.22).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ascletis Pharma's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.16.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ascletis Pharma's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 3.50.
Ascletis Pharma (OTCPK:ASCLF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ascletis Pharma's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ascletis Pharma's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ascletis Pharma Days Inventory Related Terms
Ascletis Pharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Ascletis Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASCLF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Ascletis Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascletis Pharma Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ascletis Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ascletis Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascletis Pharma (ASCLF) has a Days Inventory of 1,126.22 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ascletis Pharma and its competitors. This is 90% above median its historical median of 592.73. Over the past decade, Ascletis Pharma's Days Inventory has ranged from 161.11 to 3,528.02. According to the industry distribution chart, Ascletis Pharma ranks #575 out of 638 companies in the Biotechnology industry, placing it in the top 90.1%.
Is Ascletis Pharma's Days Inventory too high?
Ascletis Pharma's current Days Inventory of 1,126.22 is 90% above median its 10-year median of 592.73. Over the past 10 years, this metric has ranged from a low of 161.11 to a high of 3,528.02. The Biotechnology industry median Days Inventory is 183.20. Ascletis Pharma's value of 1,126.22 is 514.8% above this industry median. Based on the distribution chart, Ascletis Pharma ranks #575 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Ascletis Pharma has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ascletis Pharma's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ascletis Pharma ranks #575 out of 638 companies for Days Inventory. This places Ascletis Pharma in the lower half of its industry. The industry median Days Inventory is 183.20. Ascletis Pharma's value of 1,126.22 is 514.8% above this benchmark. Historically, Ascletis Pharma's own Days Inventory has ranged from 161.11 to 3,528.02 over the past decade. While the company's 10-year median is 592.73 vs. the industry median of 183.20, Ascletis Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ascletis Pharma's current Days Inventory of 1,126.22 is 514.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ascletis Pharma and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ascletis Pharma's current Days Inventory is 1,126.22, which is 90% above median its own 10-year median of 592.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascletis Pharma stock overvalued right now?
Based on GuruFocus' analysis, Ascletis Pharma (ASCLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $1.44 — trading 7100% above its estimated fair value. The current Days Inventory is 1,126.22, which is 90% above median its 10-year median of 592.73 and 514.8% above the Biotechnology industry median of 183.20. Ascletis Pharma's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Ascletis Pharma (ASCLF), the current Days Inventory is 1,126.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ascletis Pharma (ASCLF) Overvalued in 2026?
Based on GuruFocus' analysis, Ascletis Pharma stock appears to be overvalued.
The current stock price of $1.44 is trading 7100% above its estimated GF Value™ of $0.02.
GuruFocus considers Ascletis Pharma to be Significantly Overvalued.
Key valuation signals for ASCLF:
Days Inventory: 1,126.22 (90% above median its 10-year median of 592.73)
GF Value™: $0.02 vs. price of $1.44 (7100% above fair value)
Industry Position: 514.8% above the Biotechnology median (#575 of 638)
No single metric tells the full story. See the ASCLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ascletis Pharma Inc is an investment holding company. Along with its subsidiaries, it is engaged in the research and development, production, marketing, and sale of pharmaceutical products. The drug candidates of the company in the pipeline in their different stages of development such as ASC30, ASC47, ASC39, ASC36i, ASC35, ASC50, and among others.
38GF Score
Get the complete analysis for ASCLF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASCLF has been successfully added to your 
